Using melatonin to protect the brain in newborns with HIE during cooling treatment
Official title: Melatonin as a Neuroprotective Therapy in Neonates With HIE Undergoing Hypothermia
Run by University of Florida · NCT02621944 · Data updated 2026-11-12
This study is testing whether melatonin can help protect the brains of newborns with Hypoxic-Ischemic Encephalopathy during cooling treatment to see if it improves their long-term development.
Quick facts
| Phase | Early Phase 1 |
|---|---|
| Study type | Interventional |
| Ages | Any age to 6 Hours |
| Sex | All |
| Enrollment | 70 (estimated) |
| Sponsor | University of Florida Academic / other |
| Locations | 2 sites (Gainesville, Florida and 1 other locations) |
| Status | Recruiting |
| Started | November 9, 2016 |
| Main results expected | March 2027 |
| Study ends | March 2027 |
| Registry record updated | June 29, 2026 |
| Trial ID | NCT02621944 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are infants over 36 weeks gestation with signs of encephalopathy and who have undergone therapeutic hypothermia within 6 hours of birth.
✕Probably not a fit
Patients with suspected metabolic disorders, meningitis, or significant congenital anomalies may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the neuroprotective effects of melatonin in neonates diagnosed with Hypoxic-Ischemic Encephalopathy (HIE) who are undergoing therapeutic hypothermia. The study will enroll thirty infants and utilize a dose escalation approach, starting with a low dose of melatonin and increasing it to determine the safest and most effective dosage. Researchers will monitor serum melatonin levels, adverse events, and long-term developmental outcomes at 18-22 months of age, while also assessing the impact of melatonin on inflammation and oxidative stress related to brain injury. The goal is to identify a potential adjunct therapy that could improve neurological outcomes in affected infants.
Why it matters
Potential benefit: If successful, this study could lead to improved neurological outcomes for neonates suffering from HIE.
How similar studies have gone: While the use of melatonin in this context is novel, other studies have explored its neuroprotective properties, suggesting potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Eligible infants are \>36 0/7th weeks gestation, * pH (cord or neonatal) \<7.0, * base deficit \>16 mEq/L, * no available blood gas, * a cord blood/first hour of life blood gas with pH \> 7.0 and \< 7.15, * base deficit between 10 and 15.9 mEq/L, * infants must have a history of an acute perinatal event, * either a 10-minute Apgar \< 5 or a continued need for ventilation, * All infants must have signs of encephalopathy within 6 hours of age using the modified Sarnat scoring system, * neonates cooled within 6 hours of birth will be included in the study. Exclusion Criteria: * suspected inborn errors of metabolism (elevated ammonia) and hypoglycemia, * clinical signs and symptoms consistent with meningitis detected upon sepsis evaluation, * a diagnosis of congenital abdominal surgical problems along with multiple congenital anomalies and/or chromosomal abnormalities.
Where it's running
-
University of Florida
Gainesville, Florida, United States Recruiting -
Florida Hospital for Children
Orlando, Florida, United States Recruiting
Study contacts
- Principal investigator: Michael D Weiss, MD — University of Florida
- Study coordinator: Alison A McMurray, M.A.M.C.
- Email: amcmurra@ufl.edu
- Phone: 3526275016
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Wireless NIRS Sensor Use in the NICU for Monitoring on Neonates
A wireless NIRS sensor is tested on infants in the NICU to see how well it stays on and how it notes brain signals when used alongside standard wired sensors.
-
Neonatal Neurological Observation With Video AI
This study tests a real-time, non-contact video AI system to help monitor brain health in newborns with suspected brain injury during their hospital stay.
-
Two-week intensive brain-focused therapy program for children with neurodevelopmental and chromosomal conditions
This program will try a two-week, individualized multimodal neurorehabilitation approach for children about 4–12 years old with neurodevelopmental or chromosomal conditions to see if it improves attention, motor skills, communication, and daily functioning.
-
Genome sequencing for newborns with perinatal hypoxic‑ischemic encephalopathy
This program will try genome sequencing for newborns with moderate-to-severe hypoxic‑ischemic encephalopathy who are receiving therapeutic cooling, using parent samples to help interpret results.
-
Understanding how different anesthetics affect brain blood flow and oxygen levels during MRI
This study is testing how different types of anesthesia affect blood flow and oxygen levels in the brain during MRI scans in kids and teens.
-
Investigating eye function in babies with brain injury
This study is trying to see how eye function in babies with brain injuries affects their development over time.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.